Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7208 p121-127
27 July 2002


News summary

Pharmacy records could be used to enhance statin compliance in elderly Compliance with statin therapy among elderly patients declines substantially in as little as two years, suggesting that the benefits of treatment could be lost, according to two new studies. Researchers suggest that pharmacy records could be used to monitor patients' compliance...[more]

Statins under-prescribed in the elderly The majority of men in the United Kingdom eligible for treatment with cholesterol lowering drugs such as statins are still not getting them, despite recommendations in the National Service Framework for Coronary Heart Disease...[more]

Numark conversion to go ahead in mid-August Numark is to proceed with its plan to convert to a public limited company after receiving a 95 per cent majority in favour at an extraordinary general meeting in Birmingham on 22 July. The meeting was held to confirm the results of an initial vote on conversion which was approved by 90 per cent of shareholders...[more]

Welsh pharmacy strategy on hold until September Publication of a consultation document, the Welsh pharmacy strategy, is now expected to be in September. However, no date has yet been set...[more]

First national patient safety alert asks pharmacists to act by end of October Pharmacists are called upon to play a key role in implementing the first patient safety alert published by the National Patient Safety Agency this week...[more]

Fear of beta-blocker effects unfounded Concerns among some clinicians that beta-blockers carry a substantial risk of side effects, such as depressive symptoms, fatigue and sexual dysfunction, are unsubstantiated by clinical trial data, a new study has concluded...[more]

Ovarian cancer treatment for second-line use endorsed by NICE Pegylated liposomal doxorubicin hydrochloride (PLDH, Caelyx) should be considered as a second-line (or subsequent) treatment option for women with advanced ovarian cancer, the National Institute for Clinical Excellence has recommended...[more]

Hampshire pharmacists sent advice on minimising risks when working alone Community pharmacists in Hampshire are being sent advice on issues they should consider if they are working alone in a pharmacy or when making domiciliary visits...[more]

European directive may help contract negotiations The Government is considering the implications for pharmacy contractors of a European directive against late payments in commercial transactions. The Pharmaceutical Services Negotiating Committee may try to use the directive as a lever to get a better deal in the forthcoming new contract...[more]

Health regulators object to free movement "holiday" An alliance of United Kingdom health care regulators is objecting to draft European proposals that would allow pharmacists and other health professionals to take working holidays abroad in Europe for up to 16 weeks a year without having to register in the country they were visiting...[more]

Shipman inquiry to go on to examine CD controls The next phase of the public inquiry into how Harold Shipman was able to murder so many of his patients undetected will report on how systems for monitoring Controlled Drugs can be improved...[more]

Fife to encourage patient registration at pharmacies Fife Health Board is to encourage patients on long-term medication to register with a pharmacy of their choice as one of its priorities for implementing the Scottish pharmaceutical care strategy...[more]

Tesco stops supply of EHC to under 16s Tesco has stopped supplying emergency hormonal contraception to children under 16 years of age without a prescription after having come under pressure from pro-life pressure groups. Supplies were being made in a number of Tesco pharmacies as part of a Government pilot scheme...[more]

ABPI opposes "discriminatory" proposals on patient information European proposals to pilot the provision of information to patients by pharmaceutical companies are unfair to most people, says the Association of the British Pharmaceutical Industry...[more]

"Health literacy" impacts on diabetes Inadequate health literacy is associated with poorer glycaemic control and higher rates of retinopathy among type 2 diabetes patients, and could be contributing to the disproportionate burden of diabetes complications found among racial and ethnic minorities, a new study has concluded...[more]

Link between growth hormone and colorectal cancer not conclusive A possible link between human growth hormone therapy and an increased risk of colorectal cancer is reported by researchers...[more]

Linezolid penetrates bone and muscle Linezolid (Zyvox), an oxazolidinone antibiotic, rapidly penetrates bone, fat and muscles in patients undergoing total hip replacement, say researchers...[more]

Pharmacists to lose their right to automatic exemption from jury service Pharmacists are to lose their automatic entitlement to exemption from jury service along with certain other health care professionals...[more]

Pharmacy owners to benefit from "think small" company law reform Small companies, such as those running independent community pharmacies, should benefit from an overhaul of company law outlined by the Government last week...[more]

Zinc impairs infant mental development Giving zinc supplements to pregnant women could impair the mental development of their children, a study shows...[more]

Longer delays linked to survival Women with endometrial cancer who wait longer for treatment have a better chance of surviving, according to a new study...[more]

Sheffield LPS bid North Sheffield Primary Care Trust has made a bid for a local pharmaceutical services contract pilot for Associated Chemists (Wicker)...[more]

NICE decision on colorectal cancer drugs merits review, says DTB Recommendations made by the National Institute for Clinical Excellence on the use of irinotecan (Campto), oxaliplatin (Eloxatin) and raltitrexed (Tomudex) in patients with advanced colorectal cancer should be reviewed before the planned date of 2005...[more]

Reclassification sought for P medicine A reclassification from prescription only to pharmacy medicine status is being sought by Pharma-Global (UK) for a product which has been licensed and marketed as a pharmacy medicine for a number of years despite the fact that it contains a POM ingredient...[more]

Advice issued that epoetin alfa should be administered by intravenous injection Ortho Biotec, manufacturer of epo-etin alfa (Eprex), has advised that the product should be administered intravenously in patients with chronic renal failure where possible...[more]

Black list changes Five products are to be added to the National Health Service black list, and two removed from it, from 1 August...[more]

Pharmacist runs schools' sports day Bobby Mehta, pharmacy manager at H. A. McParland's Slough branch, recently organised a healthy heart sports day attended by over 230 local year-six pupils from five schools in Slough, Berkshire....[more]


Animal research report published...[more]

Safeway offers health checks...[more]

Nucare buys three...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal